2016 | 1/2016 (20) | 7-23
Article title

Determinanty dojrzałości modeli biznesowych

Title variants
Determinants of Business Model Maturity
Languages of publication
Celem artykułu jest praktyczna aplikacja koncepcji oceny dojrzałości modeli biznesowych na podstawie postrzeganego przez przedsiębiorcę stopnia rozwoju poszczególnych elementów modelu wpływających na tworzenie wartości dla klienta i zapewniających czerpanie korzyści z tej wartości. Do zidentyfikowania determinant dojrzałości modelu biznesowego wykorzystano wyniki badania ankietowego przeprowadzonego za pośrednictwem DELab UW na grupie respondentów, obejmujących start-upy oraz starsze przedsiębiorstwa (scale-up). W artykule zdiagnozowano wpływ wieku (fazy cyklu życia) firmy, sposobu komercjalizacji, dostępności źródeł finansowania oraz elementów kapitału intelektualnego na dojrzałość modelu biznesowego badanych przedsiębiorstw. W strukturze grupy również udział przedsiębiorstw wykorzystujących w działalności wyniki prac badawczo-rozwojowych (zarówno spośród start-up, jak i scale-up) wynosi 50%, co pozwoliło zbadać wpływ sposobu komercjalizacji i elementów kapitału intelektualnego na dojrzałość modeli biznesowych badanych podmiotów.
The goal of this article is the practical application of the concept of assessment of the maturity of a business model on the basis of the degree of development of the individual model elements that have an impact on creating value for the customer and guaranteeing benefits from that value as perceived by the entrepreneur. The results of a questionnaire-based survey as conducted through DELab of the University of Warsaw1 on a group of respondents encompassing start-ups as well as older companies (scale-ups) are presented in order to identify the determinants of the maturity of the business model. The article diagnoses the influence of age (phase in the lifecycle) of the company, its method of commercialization, accessibility of sources of financing, and elements of intellectual capital on the maturity of the business model of the investigated companies. The group structure included companies utilizing the results of research and development efforts in their operations (both start-ups and scale-ups). They accounted for 50%, which made it possible to examine the impact of method of commercialization and intellectual capital elements on the maturity of the business models of the surveyed entities.
Physical description
  • Department of Banking Finance and Accounting, Faculty of Economic Sciences and the Digital Economy Lab, University of Warsaw,
  • Department of Information Systems and Economic Analysis, Faculty of Economic Sciences and the Digital Economy Lab, University of Warsaw,
  • Aghion, P., Askenazy, P., Berman, N., Cette, G., and Eymard, L. (2012). Credit Constraints and the Cyclicality of R&D Investment: Evidence from France. Journal of the European Economic Association, 10(5), 1001–1024.
  • Corporate Information Strategy and Management: Text and Cases. McGraw-Hill.
  • Ali–Yrkkö, J. (2004). Impact of Public R&D Financing on Private R&D: Does Financial Constraint Matter? The Research Institute of the Finnish Economy (ETLA). ETLA Discussion Papers (943).
  • Almus, M. and Czarnitzki, D. (2003). The Effects of Public R&D Subsidies on Firms’ Innovation Activities: The Case of Eastern Germany. Journal of Business & Economic Statistics, 21(2), 226–236.
  • APCTT. (2008). Technology Handbook. Technology Transfer Principles and Strategy. Retrieved from: (April 8, 2014).
  • Audretsch, D.B. and Feldman, M.P. (1996). R&D Spillovers and the Geography of Innovation and Production. American Economic Review, 86(3), 630–640.
  • Bains, W. (2006). What You Give Is What You Get: Investment in European Biotechnology. Journal of Commercial Biotechnology, 12(4).
  • Bartel, A. and Lichtenberg, F. (1987). The Comparative Advantage of Educated Workers in Implementing New Technology. Review of Economics and Statistics, 69, 1–11.
  • Baden-Fuller, C. and Morgan, M. (2010). Business Models as Models. Long Range Planning, 43(2/3), 156–171.
  • Barney, J. (1991). Firm Resources and Sustained Competitive Advantage. Journal of Management, 17(1), 99–120.
  • Becker, B. and Pain, N. (2003). What Determines Industrial R&D Expenditure in the UK? National Institute of Economic and Social Research, London. Discussion Paper (217).
  • Białek-Jaworska, A. and Gabryelczyk, R. (2014). Perspektywy rozwoju przedsiębiorczości akademickiej w branży biotechnologicznej [Perspectives for the development of academic entrepreneurship in the biotechnology industry]. Warsaw: DELab, University of Warsaw.
  • Blank, S. (2013). Why the Lean Start–up Changes Everything. Harvard Business Review, 91(5), 63–72.
  • Brown, J.R., Fazzari, S.M. and Petersen, B.C. (2009). Financing Innovation and Growth: Cash
  • Flow, External Equity, and the 1990s R&D Boom. The Journal of Finance, 64(1), 151–185.
  • Bureth, A., Penin, J. and Wolff, S. (2010). Start–up Creation in Biotechnology: Lessons from the Case of Four New Ventures in The Upper Rhine Biovalley. International Journal of Innovation Management, 14(2), 253–283.
  • Carroll, R. and Tansey, R. (2000). Intellectual Capital in the New Internet Economy. Its Meaning, Measurement and Management for Enhancing Quality. Journal of Intellectual Capital, 1(4), 296–311.
  • Casadesus–Masanell, R. and Zhu, F. (2013). Business Model Innovation and Competitive Imitation: The Case of Sponsor–Based Business Models. Strategic Management Journal, 34, 464–482.
  • Chesbrough, H. (2010). Business Model Innovation: Opportunities and Barriers. Long Range Planning, 43, 354–363.
  • Chesbrough, H. and Rosenbloom, R. S. (2002). The Role of the Business Model in Capturing Value from Innovation: Evidence from Xerox Corporation’s Technology Spin–off Companies. Industrial and Corporate Change, 11(3), 529–555.
  • Christensen, C. (2010). Innowacje. Następny krok [Innovations: The next step]. Warsaw: Studio Emka.
  • Colombo, M.G. and Grilli, L. (2005). Founders’ Human Capital and the Growth of New Technology- Based Firms: A Competence-Based View. Research Policy, 34(6), 795–816.
  • Corkindale, D. (2010). Towards a Business Model for Commercializing Innovative New Technology. International Journal of Innovation and Technology Management, 7(01), 37–51.
  • Cooper, R. (2001). Stage-Gate Systems: A New Tool for Managing New Products. Business Horizons, 33(3).
  • Crosby, P. (1979). Quality is Free: The Art of Making Quality Certain. New York, NY: McGraw-Hill.
  • De Geeter, M. (2004). Technology Commercialization Manual. Strategy, Tactics, and Economics for Business Success. Champaign, Illinois: Med-Launch, Inc.
  • Edvinsson, L. and Sullivan, P. (1996). Developing a Model for Managing Intellectual Capital. European Management Journal, 14(4), 356–64.
  • Evans, D. and Leighton, L. (1989). Some Empirical Aspects of Entrepreneurship. The American Economic Review, 79(3).
  • Falk, M. (2006). What Drives Business Research and Development (R&D) Intensity across Organisation for Economic Co-operation and Development (OECD) countries? Applied Economics, 38, 533–547.
  • Gertler, M. (1988). Financial Structure and Aggregate Economic Activity. Journal of Money, Credit and Banking, 20, 559–588.
  • Gibson, D.L., Goldenson, D.R. and Kost, K. (2006). Performance Results of CMMI®-Based Process Improvement. Technical Report CMU/SEI-2006-004. Pittsburgh: Carnegie Mellon University, Software Engineering Institute.
  • Gorodnichenko, Y. and Schnitzer, M. (2010). Financial Constraints and Innovation: Why Poor Countries Don’t Catch Up. NBER Working Paper 15792.
  • Gwarda-Gruszczyńska, E. (2013). Modele procesu komercjalizacji nowych technologii w przedsiębior stwach. Uwarunkowania wyboru – kluczowe obszary decyzyjne [Models for new technology commercialization processes in companies: Selection criteria – key decision–making areas]. Łódź: Wydawnictwo Uniwersytetu Łódzkiego [Łódź University Publishing House].
  • Jabłoński, M. (2013). Kształtowanie modeli biznesu w procesie kreacji wartości przedsiębiorstw [Shaping models for businesses in the process of creating company value]. Warsaw: Difin.Johnson, M.W., Christensen, C.M. and Kagermann, H. (2008). Reinventing Your Business Model. Harvard Business Review, 12, 59–68.
  • Jolly, V. (1997). Commercializing New Technologies. Getting from Mind to Market. Boston: Harvard Business School Press.
  • Klette, T.J. and Møen, J. (2012). R&D Investment Responses to R&D Subsidies: A Theoretical Analysis and a Microeconometric Study. World Review of Science, Technology and Sustainable Development, 9(2), 169–203.
  • Lee, M.H. and Hwang, I.J. (2003). Determinants of Corporate R&D Investment: An Empirical Study Comparing Korea’s IT industry with Its non-IT Industry. ETRI Journal, 25(4), 258–265.
  • Lerner, J., Shane, H. and Tsai, A. (2003). Do Equity Financing Cycles Matter? Evidence from Biotechnology Alliances. Journal of Financial Economics, 67, 411–46.
  • Magretta, J. (2002). Why Business Models Matter. Harvard Business Review, 80(5), 86–92.
  • Mahadevan, B. (2000). Business Models for Internet- based E-commerce. California Management Review, 42(4), 55–69.
  • McGrath, R.G. (2012). When Your Business Model Is in Trouble. Harvard Business Review, 96–98.
  • McKinsey (2010). McKinsey Global Survey: Innovation and Commercialization. Retrieved from: (April 10, 2014).
  • Mitchell, W. and Singh, K. (1996). Survival of Businesses Using Collaborative Relationship to Commercialize Complex Goods. Strategic Management Journal, 17(3), 169–195.
  • Morris, M., Schindehutte, M. and Allen, J. (2005). The Entrepreneur’s Business Model: Towards a Unified Perspective. Journal of Business Research, 58(6), 726–735.
  • Nenonen, S. and Storbacka, K. (2010). Business Model Design: Conceptualizing Networked Value Co–creation. International Journal of Quality and Service Sciences, 2(1), 43–59.
  • Niosi, J. (2003). Alliances Are Not Enough Explaining Rapid Growth in Biotechnology Firms. Research Policy, 32(5), 737–750.
  • Orłowski, W. (2013). Komercjalizacja badań naukowych w Polsce. Bariery i możliwości ich przełamania [Commercialization of scientific research in Poland: Barriers and possibilities of overcoming them]. PwC Report. Retrieved from:–komercjalizacja–badan–naukowych–w–polsce–bariery–i–mozliwosci–ich–przelamania (April 24, 2014).
  • Österwalder, A. and Pigneur, Y. (2010). Business Model Generation: A Handbook for Visionaries, Game Changers, and Challengers. John Wiley & Sons.
  • Pelle, D., Bober, M., and Lis, M. (2008). Parki technologiczne jako instrument polityki wspierania innowacji i dyfuzji wiedzy [Technology parks as instruments of policies supporting innvation and the diffusion of knoweldge]. Warsaw: Instytut Badań Strukturalnych [Institute for Structural Research].
  • Pellikka, J.T. and Malinen, P. (2014). Business Models in the Commercialization Processes of Innovation among Small High-Technology Firms. International Journal of Innovation and Technology Management, 11(2).
  • Pénin, J. (2005). Patents Versus Ex–post Rewards: A New Look. Research Policy, 34(5), 641–656.
  • Powell, W.W., Koput, K.W. and Smith-Doerr, L. (1996). Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotech. Administrative Science Quarterly, 41(1), 116–145.
  • Ries, E. (2011). The Lean Startup: How Today’s Entrepreneurs Use Continuous Innovation to Create Radically Successful Businesses. Crown Publishing.
  • Roos, G., Pike, S., and Fernstrom, L. (2005). Managing Intellectual Capital in Practice. New York: Elsevier Butterworth–Heinemann.
  • Shane, S. (2004). Academic Entrepreneurship: University Spinoffs and Wealth Creation. Cheltenham, UK, Northampton, Massachusetts, USA: Edward Elgar Publishing.
  • Shimasaki, C.D. (2009). The Business of Bioscience: What Goes into Making a Biotechnology Product. London–New York: Springer. Tayles, M., Webster, M., Sugden, D. and Bramley, A. (2005). Accounting “Gets Real” in Dealing with Virtual Manufacturing. Journal of Intellectual Capital, 6(3), 322–338.
  • Teece, D. (2010). Business Models, Business Strategy and Innovation. Long Range Planning, 43(2/3), 172–194.
  • Thore, S. (2002). Technology Commercialization: DEA and Related Analytical Methods for Evaluating the Use and Implementation of Technical Innovation. Boston– Dordrecht–London: Kluwer Academic Publishers.
  • Zucker, L.G., Darby, M.R. and Brewer, M.B. (1998). Intellectual Human Capital and the Birth of US Biotechnology Enterprises. American Economic Review, 88(1), 290–305.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.